The Gallup analysis finds the largest concentrations in the West â and not just in the expected places like San Francisco and Portland, Ore. Among the nationâs 50 largest metropolitan areas, Denver and Salt Lake City are also in the top 10.
The most significant cost increase occurred in treatment for people with melanoma, the deadliest type of skin cancer. The study found that the cost of treatment jumped 106 percent, rising from $2,320 annually to $4,789 annually.
Celgene has not yet said publicly what the price of Pomalyst will be. However, it has confirmed with The Beacon published reports that Pomalyst will cost about $10,500 per 28-day cycle, based on a 21-out-of-28-day dosing regimen. At that price, Pomalyst will be the most expensive treatment for multiple myeloma.